Gene Therapy Market size is expected to grow from US$ 6.21 Bn. in 2021 to US$ 44.51 Bn. by 2029, growing at a CAGR of 27.9% through 2022 to 2029.
Gene Therapy Market Overview
The market overview of the Gene Therapy industry focuses on the detailed dynamics of the market, including aspects such as industry rivalry. The report provides comprehensive market revenue forecasts at the global, regional, segment, and national levels. A key highlight of the report is the sales forecasting for each segment and region.
Available Exclusive Sample Copy of this Report: https://www.maximizemarketresearch.com/request-sample/85074
Gene Therapy Market Report Scope and Research Methodology
The research methodology employed in the report on the Gene Therapy Market incorporates both primary and secondary research methods. Primary research involves data collection directly from the market via surveys, interviews, and observations. In contrast, secondary research entails gathering data from published sources, such as industry reports, company websites, and news articles
The analysis serves as a guide for stakeholders, investors, market players, followers, and new entrants, offering a comprehensive view of the Gene Therapy market. This information aids in formulating investment approaches and marketing tactics. The bottom-up approach was utilized to estimate the size of the Gene Therapy market. The approach involves aggregating data from individual segments to arrive at a total market size estimate.
Gene Therapy Market Regional Insights
The market is segmented by region into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Additionally, the report identifies the top countries in each region and provides market forecasts for each one.
Gene Therapy Market Segmentation
Acute Lymphoblastic Leukaemia (ALL), Inherited Retinal Disease, Large B-cell Lymphoma, ADA-SCID, Melanoma (lesions), Beta-Thalassemia Major/SCD, Head Neck Squamous Cell Carcinoma, Peripheral Arterial Disease, Spinal Muscular Atrophy (SMA), and Others are the different indications that the market is divided into. By holding a 41% market share in 2021, the Spinal Muscular Atrophy (SMA) sector is anticipated to maintain its dominance through the year 2029. SMA, one of the most common fatal genetic childhood diseases, affects the muscles. As a gene treatment, Zolgensma (AVXS-101) has proven to be effective in curing SMA and changing the disease's phenotype. In May 2021, the FDA approved Zolgensma, a medication developed by Novartis to address the fundamental cause of SMA.
The market is divided into Lentivirus, AAV, Retrovirus gamma Retrovirus, Modified Herpes Simplex Virus, Adenovirus, and Non-viral Plasmid Vector based on the type of vector used. The AAV segment is anticipated to expand quickly between 2022 and 2029, with a CAGR of 27.9%. In 2021, the AAV sector had the most market share (43%). There will be a huge demand for AAV in the next years because its application has grown dramatically in recent years across several therapeutic disciplines. Their established non-pathogenicity is one of the most important factors influencing their adoption. AAV viral vector-based gene therapy research and development is being conducted by a number of firms, including Dimension Therapeutics, AGTC, Spark Therapeutics, Sangamo Biosciences, Biogen, and AveXis.
Get More Info Visit : https://www.maximizemarketresearch.com/market-report/global-gene-therapy-market/85074/
Gene Therapy Market Key Players
• REGENXBIO, Inc.
• Bayer
• Oxford BioMedica plc
• Dimension Therapeutics, Inc.
• Bristol-Myers Squibb Company
• SANOFI
• Applied Genetic Technologies Corp
• F. Hoffmann-La Roche Ltd.
• Bluebird Bio, Inc.
• Novartis AG
• Taxus Cardium Pharmaceuticals Group, Inc. (Gene Biotherapeutics)
• UniQure N.V.
• Shire Plc;
• Cellectis S.A.
• Sangamo Therapeutics, Inc.
• Orchard Therapeutics
• Gilead Lifesciences, Inc.
• Benitec Biopharma Ltd.
• Sibiono GeneTech Co., Ltd.
• Shanghai Sunway Biotech Co., Ltd
• Gensight Biologics S.A.
• Transgene
• Calimmune, Inc
• Epeius Biotechnologies Corp
• Astellas Pharma, Inc
Table Of Content:
1. Global Gene Therapy Market: Research Methodology
2. Global Gene Therapy Market: Executive Summary
2.1 Market Overview and Definitions
2.1.1. Introduction to Global Gene Therapy Market
2.2. Summary
2.2.1. Key Findings
2.2.2. Recommendations for Investors
2.2.3. Recommendations for Market Leaders
2.2.4. Recommendations for New Market Entry
3. Global Gene Therapy Market: Competitive Analysis
3.1 MMR Competition Matrix
3.1.1. Market Structure by region
3.1.2. Competitive Benchmarking of Key Players
3.2 Consolidation in the Market
3.2.1 MA by region
3.3 Key Developments by Companies
3.4 Market Drivers
3.5 Market Restraints
3.6 Market Opportunities
3.7 Market Challenges
3.8 Market Dynamics
3.9 PORTERS Five Forces Analysis
3.10 PESTLE
3.11 Regulatory Landscape by region
• North America
• Europe
• Asia Pacific
• The Middle East and Africa
• South America
3.12 COVID-19 Impact
Speak with our research analyst: https://www.maximizemarketresearch.com/request-sample/85074
Key questions answered in the Gene Therapy Market are:
- What is Gene Therapy?
- What are the factors driving the Gene Therapy Market growth?
- What are the factors are limiting the Gene Therapy Market growth?
- What was the Gene Therapy market size in 2021?
- Which trends are expected to generate additional revenue for the Gene Therapy market growth?
- What are the recent industry trends that can be implemented to generate additional revenue streams for the Gene Therapy Market?
- What growth strategies are the players considering to increase their foothold in the Gene Therapy Market?
- Who held the largest market share in the Gene Therapy Market?
Key Offerings:
- Past Market Size and Competitive Landscape (2018 to 2021)
- Past Pricing and price curve by region (2018 to 2021)
- Market Size, Share, Size Forecast by different segment | 2022−2029
- Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by region
- Market Segmentation – A detailed analysis by segment with their sub-segments and Region
- Competitive Landscape – Profiles of selected key players by region from a strategic perspective
- Competitive landscape – Market Leaders, Market Followers, Regional player
- Competitive benchmarking of key players by region
- PESTLE Analysis
- PORTER’s analysis
- Value chain and supply chain analysis
- Legal Aspects of business by region
- Lucrative business opportunities with SWOT analysis
- Recommendations
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
+91 96071 95908, +91 9607365656
